880 related articles for article (PubMed ID: 30424539)
21. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
Morrison JC; Blanco LZ; Vang R; Ronnett BM
Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
[TBL] [Abstract][Full Text] [Related]
22. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
23. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma.
Howitt BE; Hanamornroongruang S; Lin DI; Conner JE; Schulte S; Horowitz N; Crum CP; Meserve EE
Am J Surg Pathol; 2015 Mar; 39(3):287-93. PubMed ID: 25581732
[TBL] [Abstract][Full Text] [Related]
24. Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
Yoon JY; Chapel DB; Goebel E; Qian X; Mito JK; Horowitz NS; Miron A; Soong TR; Xian W; Crum CP
J Pathol; 2022 Jul; 257(3):255-261. PubMed ID: 35238033
[TBL] [Abstract][Full Text] [Related]
25. The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.
Kobayashi H; Iwai K; Niiro E; Morioka S; Yamada Y; Ogawa K; Kawahara N
Biomed Rep; 2017 Sep; 7(3):209-213. PubMed ID: 28811894
[TBL] [Abstract][Full Text] [Related]
26. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
[TBL] [Abstract][Full Text] [Related]
27. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
[TBL] [Abstract][Full Text] [Related]
28. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary.
Gutkin DW; Shurin MR; El Azher MA; Shurin GV; Velikokhatnaya L; Prosser D; Shin N; Modugno F; Stemmer P; Elishaev E; Lokshin A
Cancer Biomark; 2019; 26(4):471-479. PubMed ID: 31658047
[TBL] [Abstract][Full Text] [Related]
29. Ki-67 labeling index as an adjunct in the diagnosis of serous tubal intraepithelial carcinoma.
Kuhn E; Kurman RJ; Sehdev AS; Shih IeM
Int J Gynecol Pathol; 2012 Sep; 31(5):416-22. PubMed ID: 22833080
[TBL] [Abstract][Full Text] [Related]
30. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
[TBL] [Abstract][Full Text] [Related]
31. High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women.
Wang J; Wu H; Zhang Y; Zhang Y; Li X; Zhao Q; Meng F; Huang Q; Wang Y
Int J Clin Exp Pathol; 2017; 10(8):8222-8232. PubMed ID: 31966673
[TBL] [Abstract][Full Text] [Related]
32. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.
Kuhn E; Meeker A; Wang TL; Sehdev AS; Kurman RJ; Shih IeM
Am J Surg Pathol; 2010 Jun; 34(6):829-36. PubMed ID: 20431479
[TBL] [Abstract][Full Text] [Related]
33. Defining the molecular evolution of extrauterine high grade serous carcinoma.
Beirne JP; McArt DG; Roddy A; McDermott C; Ferris J; Buckley NE; Coulter P; McCabe N; Eddie SL; Dunne PD; O'Reilly P; Gilmore A; Feeney L; Ewing DL; Drapkin RI; Salto-Tellez M; Kennedy RD; Harley IJG; McCluggage WG; Mullan PB
Gynecol Oncol; 2019 Nov; 155(2):305-317. PubMed ID: 31493898
[TBL] [Abstract][Full Text] [Related]
34. Evidence of a Monoclonal Origin for Bilateral Serous Tubal Intraepithelial Neoplasia.
Meserve EE; Strickland KC; Miron A; Soong TR; Campbell F; Howitt BE; Crum CP
Int J Gynecol Pathol; 2019 Sep; 38(5):443-448. PubMed ID: 29901519
[TBL] [Abstract][Full Text] [Related]
35. Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
Eckert MA; Pan S; Hernandez KM; Loth RM; Andrade J; Volchenboum SL; Faber P; Montag A; Lastra R; Peter ME; Yamada SD; Lengyel E
Cancer Discov; 2016 Dec; 6(12):1342-1351. PubMed ID: 27856443
[TBL] [Abstract][Full Text] [Related]
36. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
Chien YW; Wang Y; Huang P; Lawson BC; Kolin DL; Chui MH; Vang R; Numan TA; Soong TR; Wang BG; Smith SA; Chen CL; Stone R; Douville C; Wang TL; Shih IM
Am J Surg Pathol; 2024 Apr; 48(4):475-486. PubMed ID: 38298022
[TBL] [Abstract][Full Text] [Related]
37. Tubal origin of ovarian cancer - the double-edged sword of haemoglobin.
Lin SF; Gerry E; Shih IM
J Pathol; 2017 May; 242(1):3-6. PubMed ID: 28054715
[TBL] [Abstract][Full Text] [Related]
38. Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions.
Wu RC; Wang P; Lin SF; Zhang M; Song Q; Chu T; Wang BG; Kurman RJ; Vang R; Kinzler K; Tomasetti C; Jiao Y; Shih IM; Wang TL
J Pathol; 2019 May; 248(1):41-50. PubMed ID: 30560554
[TBL] [Abstract][Full Text] [Related]
39. High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report With Literature Review.
Novikov FV; Anufriev AG; Efremov GD
Int J Gynecol Pathol; 2024 Apr; ():. PubMed ID: 38661558
[TBL] [Abstract][Full Text] [Related]
40. Changes in the Extracellular Matrix Are Associated With the Development of Serous Tubal Intraepithelial Carcinoma Into High-Grade Serous Carcinoma.
van der Steen SCHA; Bulten J; Van de Vijver KK; van Kuppevelt TH; Massuger LFAG
Int J Gynecol Cancer; 2017 Jul; 27(6):1072-1081. PubMed ID: 28333845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
